Long‐term follow‐up of immunosuppressive monotherapy in liver transplantation: tacrolimus and microemulsified cyclosporin

Cholongitas E, Shusang V, Germani G, Tsochatzis E, Raimondo ML, Marelli L, Senzolo M, Davidson BR, Patch D, Rolles K, Burroughs AK. Long‐term follow‐up of immunosuppressive monotherapy in liver transplantation: tacrolimus and microemulsified cyclosporin.
Clin Transplant 2011: 25: 614–624. © 2010 John Wiley & Sons A/S.

[1]  E. Cholongitas,et al.  Outcome of recurrent hepatitis C virus after liver transplantation in a randomized trial of tacrolimus monotherapy versus triple therapy , 2009, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[2]  L. Stevens,et al.  Conceptual model of CKD: applications and implications. , 2009, American Journal of Kidney Diseases.

[3]  Olga Ciccarelli,et al.  Tacrolimus Monotherapy in Liver Transplantation: One-Year Results of a Prospective, Randomized, Double-Blind, Placebo-Controlled Study , 2008, Annals of surgery.

[4]  O. Abbasoğlu.  Liver transplantation: yesterday, today and tomorrow. , 2008, World journal of gastroenterology.

[5]  P. Thuluvath,et al.  Steroid avoidance in liver transplantation: Meta‐analysis and meta‐regression of randomized trials , 2008, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[6]  E. Cholongitas,et al.  Review article: renal function assessment in cirrhosis – difficulties and alternative measurements , 2007, Alimentary pharmacology & therapeutics.

[7]  M. Masetti,et al.  Sirolimus monotherapy in liver transplantation. , 2007, Transplantation proceedings.

[8]  D. Elbourne,et al.  Randomized Controlled Trial of Tacrolimus Versus Microemulsified Cyclosporin (TMC) in Liver Transplantation: Poststudy Surveillance to 3 Years , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[9]  R. Malthaner,et al.  Cyclosporin versus tacrolimus for liver transplanted patients. , 2006, The Cochrane database of systematic reviews.

[10]  F. Reinholt,et al.  Liver biopsy interpretation for causes of late liver allograft dysfunction , 2006, Hepatology.

[11]  R. Malthaner,et al.  Cyclosporin versus Tacrolimus as Primary Immunosuppressant After Liver Transplantation: A Meta‐Analysis , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[12]  C. Sabin,et al.  3-month and 12-month mortality after first liver transplant in adults in Europe: predictive models for outcome , 2006, The Lancet.

[13]  I. Bilbao,et al.  A prospective randomized trial comparing tacrolimus and steroids with tacrolimus monotherapy in liver transplantation: the impact on recurrence of hepatitis C , 2005, Transplant international : official journal of the European Society for Organ Transplantation.

[14]  I. Bilbao,et al.  Five-year follow-up of a trial comparing Tacrolimus and cyclosporine microemulsion in liver transplantation. , 2005, Transplantation proceedings.

[15]  P. Neuhaus,et al.  Withdrawal of steroids: a randomized prospective study of prednisone and tacrolimus versus mycophenolate mofetil and tacrolimus in liver transplant recipients with autoimmune hepatitis. , 2005, Transplantation proceedings.

[16]  A. Johnston,et al.  Novel therapies in transplantation , 2005, Expert opinion on investigational drugs.

[17]  T. Starzl,et al.  Tacrolimus for primary liver transplantation: 12 to 15 years actual follow-up with safety profile. , 2005, Transplantation proceedings.

[18]  G. Klintmalm,et al.  Estimation of glomerular filtration rates before and after orthotopic liver transplantation: Evaluation of current equations , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[19]  D. Elbourne,et al.  Tacrolimus versus microemulsified ciclosporin in liver transplantation: the TMC randomised controlled trial , 2002, The Lancet.

[20]  H. Schlitt,et al.  Clinical and subclinical acute rejection early after liver transplantation: contributing factors and relevance for the long-term course. , 2001, Transplantation.

[21]  V. Lánská,et al.  Withdrawal of steroids from triple-drug therapy in kidney transplant patients. , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[22]  C. Bodian,et al.  Long-term medical complications in patients surviving > or = 5 years after liver transplant. , 2000, Transplantation.

[23]  B. Davidson,et al.  A pilot study of immunosuppressive monotherapy in liver transplantation: tacrolimus versus microemulsified cyclosporin. , 1999, Transplantation.

[24]  R. Wiesner,et al.  Acute hepatic allograft rejection: Incidence, risk factors, and impact on outcome , 1998, Hepatology.

[25]  A. Burroughs,et al.  Long-term immunosuppression without corticosteroids after orthotopic liver transplantation: a positive therapeutic aim. , 1996, Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[26]  R. Stratta,et al.  Morbidity in patients with posttransplant diabetes mellitus following orthotopic liver transplantation. , 1996, Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[27]  M. Stegall,et al.  Metabolic complications after liver transplantation. Diabetes, hypercholesterolemia, hypertension, and obesity. , 1995, Transplantation.

[28]  A. Dhillon,et al.  Grading of cellular rejection after orthotopic liver transplantation , 1995, Hepatology.

[29]  P. Neuhaus,et al.  Corticosteroids and concomitant medication in the European multicentre study of FK 506 and cyclosporin in primary liver transplantation , 1994, Transplant international : official journal of the European Society for Organ Transplantation.

[30]  F. Romani,et al.  Cyclosporin monotherapy (after 3 months) in liver transplant patients: a prospective randomized trial. , 1994, Transplantation proceedings.

[31]  W. Savage,et al.  GYNAECOLOGISTS' ATTITUDES TO ABORTION , 1989, The Lancet.

[32]  T. Starzl,et al.  FK 506 FOR LIVER, KIDNEY, AND PANCREAS TRANSPLANTATION , 1989, The Lancet.

[33]  D. Dunn,et al.  CYCLOSPORIN A INITIALLY AS THE ONLY IMMUNOSUPPRESSANT IN 34 RECIPIENTS OF CADAVERIC ORGANS: 32 KIDNEYS, 2 PANCREASES, AND 2 LIVERS , 1979, The Lancet.

[34]  D. Dunn,et al.  CYCLOSPORIN A IN PATIENTS RECEIVING RENAL ALLOGRAFTS FROM CADAVER DONORS , 1978, The Lancet.

[35]  A. Burroughs,et al.  Single-agent immunosuppression after liver transplantation: what is possible? , 2002, Drugs.

[36]  P. Kandela.  South Africa: medical care of detainees. , 1985, Lancet.